Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| BrainCheck | 2026 | Series A | $13.0M | Houston |
| Versiti | 2026 | Grant | $3.0M | Milwaukee |
| Perspective Therapeutics | 2026 | Post Ipo Equity | $175.0M | Seattle |
| Clene Nanomedicine | 2026 | Post Ipo Equity | $28.0M | Salt Lake City |
| Novoron Bioscience | 2026 | Grant | $2.5M | San Diego |
| Trethera | 2025 | Grant | $2.7M | Beverly Hills |
| Eliaz Therapeutics | 2025 | Equity Crowdfunding | $3.2M | Santa Rosa |
| Azitra | 2025 | Post Ipo Equity | $1.5M | Branford |
| GreenMark Biomedical | 2025 | Grant | $300K | East Lansing |
| iQure Pharma | 2025 | Series Unknown | $1.5M | Wilmington |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 51 | BrainCheck | Series A | $13.0M | Houston, United States |
| 52 | Versiti | Grant | $3.0M | Milwaukee, United States |
| 53 | Perspective Therapeutics | Post Ipo Equity | $175.0M | Seattle, United States |
| 54 | Clene Nanomedicine | Post Ipo Equity | $28.0M | Salt Lake City, United States |
| 55 | Novoron Bioscience | Grant | $2.5M | San Diego, United States |
| 56 | Trethera | Grant | $2.7M | Beverly Hills, United States |
| 57 | Eliaz Therapeutics | Equity Crowdfunding | $3.2M | Santa Rosa, United States |
| 58 | Azitra | Post Ipo Equity | $1.5M | Branford, United States |
| 59 | GreenMark Biomedical | Grant | $300K | East Lansing, United States |
| 60 | iQure Pharma | Series Unknown | $1.5M | Wilmington, United States |
BrainCheck is a digital platform for cognitive assessment and care that evaluates brain health across clinical and non-clinical settings.
Versiti provide innovative, value added solutions in the fields of transfusion medicine, transplantation, and blood-related diseases.
Perspective Therapeutics focuses on advancing cancer treatments employing radiation, radiopharmaceuticals, and imaging technology.
Clene Nanomedicine focuses on the development of unique therapeutics for neurodegenerative diseases.
Biotechnology company developing pharmaceutical therapies for nerve regeneration in the central nervous system.
Trethera is a biotechnology company that discovers and develops small molecules that control DNA replication and integrity.
Eliaz Therapeutics is developing a novel treatment using targeted therapeutic apheresis to remove Galetin-3 from the body
Azitra is a clinical-stage medical dermatology company developing microbiome-based novel therapeutics to treat skin conditions and diseases.
GreenMark is a healthcare company providing health-based benefits using nanoparticles.
iQure Pharma is a global biotech company that develops new therapeutics for patients and physicians.
Rendever is a research-based virtual reality platform that provides cognitive stimulation, socialization, and therapy for older adults.
Burst Diagnostics engages in the future of at-home and point-of-care testing.
Co-Diagnostics is a molecular diagnostics company that enhances the output of molecular diagnostic tests.
CND Life Sciences is a medical technology company that develops evidence-based tool to assist physicians in diagnosing synucleinopathy.
RIVANNA commercializes ultrasound technologies that reduce the patient risk caused by radiation from X-ray-based medical imaging.
Juniper Biomedical is a neuromodulation MedTech company that is dramatically improving therapy for patients with pelvic health conditions.
TransCode Therapeutics is an RNA oncology company that develops and commercializes drugs for the treatment of metastatic cancer.
Neuronoff is a medical device developing comapny.
Averto Medical is a medical device manufacturing company.
RevBio was started with one goal in mind—to end medicine’s 50-year search for a biocompatible bone adhesive.
A digital health platform that uses analysis of eye-movements as a biomarker to assess brain health across neurological disorders.
Psilera is a biotechnology company that develops treatments for neurological and psychiatric disorders.
Regenerative Medical Solutions is a biotechnology company developing regenerative medical products used to treat diabetes.
CytoAgents is a biotechnology company focused on the the treatment of COVID-19, Influenza, and other viral infectious diseases.
POP Biotechnologies LLC is Buffalo NY biotechnology company.
National Institutes of Health has invested in 288 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
National Institutes of Health's top investment sectors include Health Care, Biotechnology, Medical Device, Medical, Life Science. The firm invests across 27 different industry categories.
Among tracked funding rounds, Perspective Therapeutics received $175.0M in a Post Ipo Equity round. National Institutes of Health's total known invested capital is $1.3B.
National Institutes of Health's average investment size is $6.6M across its portfolio of 288 companies.
Recent National Institutes of Health portfolio additions include BrainCheck, Versiti, Perspective Therapeutics, Clene Nanomedicine, Novoron Bioscience. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors